GlaxoSmithKline: all 4,196 studies
Page 8 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes MellitusCompletedNCT02683746Phase 3Results posted
- A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan AdultsCompletedNCT02676895Phase 2Results posted
- A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis SubjectsCompletedNCT02673619Phase 2Results posted
- Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea.CompletedNCT02663102Results posted
- Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian CancerCompletedNCT02657889Phase 1/2Results posted
- A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based ChemotherapyActive, not recruitingNCT02655016Phase 3Results posted
- Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma PatientsCompletedNCT02654145Phase 4Results posted
- A Study to Investigate Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Pain Derived From Exposed Dentine in Response to Chemical, Thermal, Tactile, or Osmotic Stimuli.CompletedNCT02651467Not applicableResults posted
- First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy SubjectsCompletedNCT02647281Phase 1Results posted
- Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth SymptomsCompletedNCT02641912Not applicableResults posted
- Safety of 4CMenB Exposure During PregnancyCompletedNCT02640677Results posted
- Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate VaccineCompletedNCT02639351Phase 1Results posted
- A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy VolunteersCompletedNCT02634073Phase 4Results posted
- Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's SyndromeCompletedNCT02631538Phase 2Results posted
- Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid TumorsTerminatedNCT02630251Phase 1Results posted
- THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROCCompletedNCT02625207Phase 1Results posted
- Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus VulgarisTerminatedNCT02613910Phase 3Results posted
- The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal HypersensitivityCompletedNCT02612064Not applicableResults posted
- Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed ConditionsCompletedNCT02605395Phase 4Results posted
- A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic AmyloidosisTerminatedNCT02603172Phase 1Results posted
- Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients With APDS/PASLICompletedNCT02593539Phase 2Results posted
- Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02588612Phase 1Results posted
- Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With AsthmaCompletedNCT02586506Phase 4Results posted
- Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD SubjectsCompletedNCT02586493Phase 4Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years EarlierCompletedNCT02581410Phase 3Results posted
- Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary DiseaseCompletedNCT02573870Phase 2Results posted
- Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02570165Phase 2Results posted
- A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South AsiaCompletedNCT02570152Not applicableResults posted
- A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.CompletedNCT02570126Phase 3Results posted
- A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled AsthmaCompletedNCT02567708Phase 2Results posted
- A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)CompletedNCT02564055Phase 2Results posted
- A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque PsoriasisCompletedNCT02564042Phase 2Results posted
- Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary HyperhidrosisCompletedNCT02563899Phase 2Results posted
- A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) MalariaCompletedNCT02563496Phase 2Results posted
- DUAC® Early Onset Efficacy Study in Japanese SubjectsCompletedNCT02557399Phase 4Results posted
- Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma PatientsCompletedNCT02555371Phase 3Results posted
- Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) PatientsCompletedNCT02551653Phase 1Results posted
- Intra Oral Kinetics of Fluoride Containing DentifricesCompletedNCT02548156Not applicableResults posted
- A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in ChildrenCompletedNCT02548078Phase 2Results posted
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.CompletedNCT02547974Phase 1Results posted
- A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.CompletedNCT02545517Phase 3Results posted
- Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal HypersensitivityCompletedNCT02542943Not applicableResults posted
- A Study to Investigate the Impact of Fortified Malt Based on Immunity Outcomes in School ChildrenCompletedNCT02542865Not applicableResults posted
- In Vivo Investigation of Initial Stages of Enamel ErosionCompletedNCT02533466Not applicableResults posted
- Efficacy and Safety Study of Sirukumab in Patients With Giant Cell ArteritisTerminatedNCT02531633Phase 3Results posted
- GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)CompletedNCT02528357Phase 1Results posted
- 8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat AcneCompletedNCT02524665Phase 4Results posted
- A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute ExacerbationCompletedNCT02522299Phase 2Results posted
- Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)CompletedNCT02515630Phase 2Results posted
- Bioequivalence Study for Mejoral 500 ProductCompletedNCT02504775Not applicableResults posted
- Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid ArthritisCompletedNCT02504671Phase 2Results posted
- Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With AsthmaCompletedNCT02502734Phase 3Results posted
- A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart FailureCompletedNCT02497937Phase 2Results posted
- A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy SubjectsCompletedNCT02496221Phase 4Results posted
- A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy AdultsCompletedNCT02491463Phase 1Results posted
- Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in FranceCompletedNCT02487472Results posted
- A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in AdultsCompletedNCT02485301Phase 2Results posted
- Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With AsthmaCompletedNCT02483975Phase 3Results posted
- Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine RegimenCompletedNCT02478632Phase 3Results posted
- Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult VolunteersCompletedNCT02478463Phase 1Results posted
- Safety, Tolerability and Clinical Effect of Danirixin in Adults With InfluenzaCompletedNCT02469298Phase 2Results posted
- Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusCompletedNCT02465515Phase 4Results posted
- A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)CompletedNCT02451514Phase 2Results posted
- Exploratory Study of Biotelemetry in Amyotrophic Lateral SclerosisCompletedNCT02447952Not applicableResults posted
- A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy InfantsCompletedNCT02447432Phase 3Results posted
- Combined Study - Phase 3b MenB Long Term Persistence in AdolescentsCompletedNCT02446743Phase 3Results posted
- Evaluation of Antibody Persistence Following 4 MenACWY VaccinationsCompletedNCT02446691Phase 4Results posted
- Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958CompletedNCT02446613Phase 2Results posted
- A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy SubjectsCompletedNCT02446496Phase 4Results posted
- A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy AdultsCompletedNCT02446483Phase 4Results posted
- A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent AsthmaCompletedNCT02446418Phase 3Results posted
- Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)CompletedNCT02429791Phase 3Results posted
- Study Comparing Blood Levels of Fatty Acids After Consuming Two Forms of Cod Liver OilCompletedNCT02428699Not applicableResults posted
- Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264CompletedNCT02424799Phase 1Results posted
- Effect of Topical Application of Iodex® Balm on Local Surface TemperatureCompletedNCT02424565Phase 4Results posted
- A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)CompletedNCT02424539Phase 4Results posted
- Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)CompletedNCT02422797Phase 3Results posted
- Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryCompletedNCT02422264Phase 4Results posted
- Study to Evaluate Handling Errors in Usage of SERETIDE® Metered Dose Inhaler (MDI) (EVOHALER®) by Adult Subjects Currently Using the SERETIDE DISKUS® InhalerCompletedNCT02416180Phase 4Results posted
- A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza VaccinesCompletedNCT02415842Results posted
- Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive AdultsTerminatedNCT02415595Phase 2Results posted
- A Tolerability Assessment Study of Three Wash Products in InfantsCompletedNCT02403999Not applicableResults posted
- Evaluation of Oral Hygiene Products in an In Situ Caries ModelCompletedNCT02399163Not applicableResults posted
- Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal SpraysCompletedNCT02397915Phase 4Results posted
- Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced AdultsTerminatedNCT02386098Phase 2Results posted
- PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)TerminatedNCT02378038Phase 2Results posted
- A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm LaborTerminatedNCT02377466Phase 3Results posted
- Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in ChildrenCompletedNCT02377427Phase 2Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant WomenCompletedNCT02377349Phase 4Results posted
- A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate VaccineCompletedNCT02374450Results posted
- Clinical Study to Evaluate the Efficacy of Two Dentifrices for Dentine HypersensitivityCompletedNCT02371616Not applicableResults posted
- Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and AboveCompletedNCT02369341Phase 3Results posted
- Attachment Inhibitor Comparison in Heavily Treatment Experienced PatientsActive, not recruitingNCT02362503Phase 3Results posted
- Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy WomenCompletedNCT02360475Phase 2Results posted
- A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy RegimensCompletedNCT02354586Phase 2Results posted
- A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02345161Phase 3Results posted
- Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral CavityCompletedNCT02319668Phase 4Results posted
- Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or TrametinibTerminatedNCT02314143Phase 2Results posted
- A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With OsteoarthritisCompletedNCT02311881Phase 3Results posted
- An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent AsthmaCompletedNCT02301975Phase 3Results posted